BURLINGTON Mass. Nov. 17 2011 PRNewswire Coronado Biosciences Inc. OTCBB CNDO a company focused on novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer today announced that its common stock has been approved for quotatio...
↧